The World's Greatest Investing Community
Results 1 - 10 of 56 : 1 2 3 4 5 6 Next
Allergan Hits Estimates in Solid Quarter
Just the facts, Fool.
Bad Clinical Trial Trumps Good Acquisition
Spectrum Pharmaceuticals can't get past bad apaziquone data.
4-Star Stocks Poised to Pop: Allergan
Market-trouncing returns could be written in this 4-Star.
Wrinkled Bladder? There's a Drug for That!
Allergan's Botox works for overactive bladder.
What Allergan Does With Its Cash
Cash is king. What a company does with it matters.
Checking an Important Metric at Allergan
Don't just ask, "How much inventory?" Ask, "What kind?"
Here's Why Allergan's Earnings Are Worse Than They Look
Don't just count the cash, time it.
Just the facts, Fool.
Are Allergan's Numbers Better Than They Look?
Don't just ask, "How much inventory?" Ask, "What kind?"
How Healthy Is Opko Health's Growth?
These two simple metrics can save you a lot of pain.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK